The first prospective study (study that looks over time, ie probable cause to effect) of heart damage after Pfizer mRNA vaccinations shows an alarmingly high rate of heart damage among 13-18 year old boys.
Thai physician researchers followed 312 school-age youths (202 boys and 110 girls) aged 13-18 after a first or second Pfizer mRNA shot, and examined them with hospital and laboratory tests. The most important finding was that increased heart damage biomarkers were found in their blood after the second injection. Further cardiac function tests confirmed that these boys suffered from pericarditis or subclinical myocarditis.
This amounts to 3.5% of the vaccinated boys after the second Pfizer shot. None of the young women had elevated heart damage biomarkers.
The frequency of 3.5% is 600 times higher than the hitherto known frequency of pericarditis and myocarditis after corona vaccination in boys and young men (16-24 years) from a recent retrospective Scandinavian study. In a retrospective study, only people who are clinically noticed after complaints are included, so people with (yet) unnoticed damage are by definition excluded.
The Doctors Collective finds it remarkable that only now the first prospective study into heart damage of the mRNA vaccines has been published, because signals of heart damage were already given more than a year ago. We call on the Dutch health authorities to immediately repeat the Thai study in one or more academic hospitals in the Netherlands.
We have been calling for stopping vaccinating boys and young men with mRNA corona vaccines for some time, partly because published literature shows that heart damage occurs much more often after vaccination than after corona infection. This Thai study underscores our appeal.
While the Physicians Collective is very careful about disclosing studies that have not yet gone through the peer review process, this Thai study now sends a safety signal that is too strong to ignore.
Read the preprint of the study here.
Finally, we remind here that repeat shots for under-60s without medical indication are currently not approved by the European Medicines Authority (EMA) and therefore only off label can be given, as witnessed by a statement from Minister Kuipers on 28 June in the House of Representatives.
Support us, become a friend!
Together we stand stronger. From fear back to confidence!
Disclaimer: The Doctors Collective is not responsible for the content on the mentioned pages of external parties to which reference is made. Sharing a page does not mean that the Doctors Collective shares all views. The Doctors Collective supports the gathering and sharing of (medical) information without censorship in order to stimulate an open conversation / scientific discussion.